Johnson & Johnson’s Acquisition of Shockwave Medical for $13.1 Billion in an All-Cash Deal

On April 5, 2024,  Johnson & Johnson (JNJ) and Shockwave Medical  (SWAV) announced a merger agreement for an enterprise value of $13.1 billion.

As per the conditions of the merger, Johnson & Johnson has agreed to acquire Shockwave for $335 per share in cash.

Please subscribe for free or login to your InsideArbitrage account to access this article.